Nancy Ryan Gray serves as Executive at LIGAND PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, Nancy Ryan Gray has executed 13 insider transactions totaling $1.4M, demonstrating a bearish approach to their equity position. Their most recent transaction on Nov 7, 2025 involved exercising options for 3,015 shares valued at $221.8K.
Nancy Ryan Gray currently holds 11,109 shares of LIGAND PHARMACEUTICALS INC (LGND), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Nancy Ryan Gray has been a net seller of LGND stock. They have purchased $0 and sold $1.4M worth of shares.
Nancy Ryan Gray's most recent insider trade was on Nov 7, 2025, when they sold 3,015 shares at $73.57 per share.
Get notified when new Form 4 filings are submitted
| 3,556 |
| $66.19 |
| Discretionary |
| Nov 7, 2025 | LGND | $619.4K | Sale | 3,015 | $205.45 | Discretionary |
| Nov 7, 2025 | LGND | $730.6K | Sale | 3,556 | $205.45 | Discretionary |
| Jun 14, 2024 | LGND | $0 | Award | 1,252 | $N/A | Discretionary |
| May 9, 2024 | LGND | $77.7K | Sale | 934 | $83.20 | Discretionary |
| Jun 9, 2023 | LGND | $0 | Award | 1,142 | $N/A | Discretionary |
| Jun 10, 2022 | LGND | $0 | Award | 1,004 | $N/A | Discretionary |
| Jun 4, 2021 | LGND | $0 | Award | 630 | $N/A | Discretionary |
| Jun 10, 2020 | LGND | $0 | Award | 831 | $N/A | Discretionary |
| Jun 6, 2019 | LGND | $0 | Award | 835 | $N/A | Discretionary |
| Jun 19, 2018 | LGND | $0 | Award | 493 | $N/A | Discretionary |
| Aug 18, 2017 | LGND | $0 | Award | 913 | $N/A | Discretionary |